[go: up one dir, main page]

DE60044119D1 - Reagentien und verfahren zur erkennung von erkrankungen der brust - Google Patents

Reagentien und verfahren zur erkennung von erkrankungen der brust

Info

Publication number
DE60044119D1
DE60044119D1 DE60044119T DE60044119T DE60044119D1 DE 60044119 D1 DE60044119 D1 DE 60044119D1 DE 60044119 T DE60044119 T DE 60044119T DE 60044119 T DE60044119 T DE 60044119T DE 60044119 D1 DE60044119 D1 DE 60044119D1
Authority
DE
Germany
Prior art keywords
breast
useful
diseases
reagent
tissue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60044119T
Other languages
English (en)
Inventor
Patricia A Billing-Medel
Maurice Cohen
Tracey L Colpitts
Paula N Friedman
Julian Gordon
Edward N Granados
Steven C Hodges
Michael R Klass
Jon D Kratochvil
John C Russell
Stephen D Stroupe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Application granted granted Critical
Publication of DE60044119D1 publication Critical patent/DE60044119D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3015Breast
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/30Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/136Screening for pharmacological compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Cell Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DE60044119T 1999-01-21 2000-01-21 Reagentien und verfahren zur erkennung von erkrankungen der brust Expired - Lifetime DE60044119D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23471699A 1999-01-21 1999-01-21
PCT/US2000/001452 WO2000043420A1 (en) 1999-01-21 2000-01-21 Reagents and methods useful for detecting diseases of the breast

Publications (1)

Publication Number Publication Date
DE60044119D1 true DE60044119D1 (de) 2010-05-20

Family

ID=22882506

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60044119T Expired - Lifetime DE60044119D1 (de) 1999-01-21 2000-01-21 Reagentien und verfahren zur erkennung von erkrankungen der brust

Country Status (8)

Country Link
US (1) US20060154291A1 (de)
EP (1) EP1144449B1 (de)
JP (1) JP2002540761A (de)
AT (1) ATE463508T1 (de)
CA (1) CA2358800C (de)
DE (1) DE60044119D1 (de)
ES (1) ES2343103T3 (de)
WO (1) WO2000043420A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6969518B2 (en) 1998-12-28 2005-11-29 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US6528054B1 (en) 1998-12-28 2003-03-04 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US6680197B2 (en) 1998-12-28 2004-01-20 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US6579973B1 (en) 1998-12-28 2003-06-17 Corixa Corporation Compositions for the treatment and diagnosis of breast cancer and methods for their use
US6958361B2 (en) * 1998-12-28 2005-10-25 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US7598226B2 (en) 1998-12-28 2009-10-06 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US6586572B2 (en) * 1998-12-28 2003-07-01 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US6573368B2 (en) 1998-12-28 2003-06-03 Corixa Corporation Compositions for the treatment and diagnosis of breast cancer and methods for their use
US6844325B2 (en) 1998-12-28 2005-01-18 Corixa Corporation Compositions for the treatment and diagnosis of breast cancer and methods for their use
US6518237B1 (en) 1998-12-28 2003-02-11 Corixa Corporation Compositions for treatment and diagnosis of breast cancer and methods for their use
US6590076B1 (en) * 1999-04-02 2003-07-08 Corixa Corporation Compositions for the treatment and diagnosis of breast cancer and methods for their use
CA2392510A1 (en) 1999-11-30 2001-06-07 Corixa Corporation Compositions and methods for therapy and diagnosis of breast cancer
AU2004230328A1 (en) * 2003-04-15 2004-10-28 Sanofi Pasteur Limited Tumor antigens BFA5 for prevention and/or treatment of cancer
US8207314B2 (en) * 2003-05-16 2012-06-26 Sanofi Pasteur Limited Tumor antigens for prevention and/or treatment of cancer
US20100129289A1 (en) * 2006-05-18 2010-05-27 The Ohio State University Research Foundation Compositions and methods for the detection of vulnerable plaque

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2804445A1 (de) 1978-02-02 1979-08-09 Studiengesellschaft Kohle Mbh Verfahren zur herstellung von magnesiumhydriden
US5618695A (en) * 1995-06-07 1997-04-08 Mayo Foundation For Medical Education And Research DNA encoding HEM-1, a gene expressed by sclerosing hemangioma cells
US5736331A (en) * 1995-07-08 1998-04-07 Schering Corporation Method for identifying nucleic acids encoding c-fos promoter activating proteins
JP4614472B2 (ja) * 1996-10-31 2011-01-19 アボット・ラボラトリーズ 乳房の疾患の検出に有用な試薬および方法
WO1998059049A1 (en) * 1997-06-20 1998-12-30 Abbott Laboratories Reagents and methods useful for detecting diseases of the breast
WO1999002559A1 (en) * 1997-07-07 1999-01-21 Abbott Laboratories Reagents and methods useful for detecting diseases of the breast
WO1999025850A1 (en) * 1997-11-17 1999-05-27 Abbott Laboratories Reagents and methods useful for detecting diseases of the breast

Also Published As

Publication number Publication date
US20060154291A1 (en) 2006-07-13
ES2343103T3 (es) 2010-07-23
JP2002540761A (ja) 2002-12-03
WO2000043420A1 (en) 2000-07-27
CA2358800A1 (en) 2000-07-27
EP1144449B1 (de) 2010-04-07
CA2358800C (en) 2015-03-17
EP1144449A1 (de) 2001-10-17
ATE463508T1 (de) 2010-04-15

Similar Documents

Publication Publication Date Title
WO2000056352A3 (en) Reagents and methods useful for detecting diseases of the prostate
ATE364089T1 (de) Reagenzien und methoden zum nachweis von erkrankungen der brust
DE60044119D1 (de) Reagentien und verfahren zur erkennung von erkrankungen der brust
RU2013113439A (ru) Идентификация опухолеассоциированных антигенов для диагностики и терапии
DE69833572D1 (de) Verfahren zur bestimmung des metastasierungspotentials unter verwendung des asp1 gens
CA2395729A1 (en) NUCLEIC ACIDS, PROTEINS AND ANTIBODIES
DE60137264D1 (de) Monoklonale antikörper und zelloberflächenantigene zum nachweis und zur behandlung von kleinzelligem lungenkrebs (sclc)
ATE229073T1 (de) Protein e25a, methoden zu dessen herstellung und anwendung
ATE292801T1 (de) Verfahren zum screening von inhibitoren von asp2
WO2002062945A3 (en) Compositions and methods relating to lung specific genes and proteins
JP2010529843A5 (de)
Vadon-Le Goff et al. Identification of PCPE-2 as the endogenous specific inhibitor of human BMP-1/tolloid-like proteinases
EA200501197A1 (ru) Композиции и способы для лечения злокачественной опухоли с применением igsf9 и liv - 1
WO2002064741A3 (en) Compositions and methods relating to breast specific genes and proteins
ATE449171T1 (de) Reagentia und verfahren zum nachweis von brustkrankheiten
WO2002040673A3 (en) Compositions and methods relating to lung specific genes and proteins
WO2004050860A3 (en) Compositions, splice variants and methods relating to colon specific genes and proteins
WO2000041516A3 (en) Reagents and methods useful for detecting diseases of the breast
WO1999031274A3 (en) Reagents and methods useful for detecting diseases of the pancreas
KR101751929B1 (ko) 신규 간암 환자의 소라페닙 저항성 예측 마커
WO2004053075A3 (en) Compositions, splice variants and methods relating to breast specific genes and proteins
WO2005017102A3 (en) Compositions, splice variants and methods relating to ovarian specific nucleic acids and proteins
WO1999014357A3 (en) Reagents and methods useful for detecting diseases of the prostate, breast and ovary
WO2001065262A3 (en) Reagents and methods useful for detecting diseases of the breast
WO2003066877A3 (en) Compositions and methods relating to hepatic specific genes and proteins

Legal Events

Date Code Title Description
8364 No opposition during term of opposition